0001144204-12-048422.txt : 20120828 0001144204-12-048422.hdr.sgml : 20120828 20120828162546 ACCESSION NUMBER: 0001144204-12-048422 CONFORMED SUBMISSION TYPE: N-PX PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120630 FILED AS OF DATE: 20120828 DATE AS OF CHANGE: 20120828 EFFECTIVENESS DATE: 20120828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GMO Series Trust CENTRAL INDEX KEY: 0001521894 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: N-PX SEC ACT: 1940 Act SEC FILE NUMBER: 811-22564 FILM NUMBER: 121060304 BUSINESS ADDRESS: STREET 1: 40 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-346-7646 MAIL ADDRESS: STREET 1: 40 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02210

0001521894 S000033569 GMO U.S. Core Equity Series Fund

C000103077 Class R6

C000108415 Class R4

C000108416 Class R5

0001521894 S000035210 Quality Series Fund

C000108318 Class R4

C000108319 Class R5

C000108320 Class R6

0001521894 S000035211 Core Plus Bond Series Fund

C000108321 Class R4

C000108322 Class R5

C000108323 Class R6

0001521894 S000035212 International Bond Series Fund

C000108324 Class R4

C000108325 Class R5

C000108326 Class R6

0001521894 S000035213 Emerging Country Debt Series Fund

C000108327 Class R4

C000108328 Class R5

C000108329 Class R6

0001521894 S000035214 U.S. Equity Allocation Series Fund

C000108330 Class R4

C000108331 Class R5

C000108332 Class R6

0001521894 S000035215 International Equity Allocation Series Fund

C000108333 Class R4

C000108334 Class R5

C000108335 Class R6

0001521894 S000035216 Global Equity Allocation Series Fund

C000108336 Class R4

C000108337 Class R5

C000108338 Class R6

0001521894 S000035217 Global Asset Allocation Series Fund

C000108339 Class R4

C000108340 Class R5

C000108341 Class R6

0001521894 S000035218 Benchmark-Free Allocation Series Fund

C000108342 Class R4

C000108343 Class R5

C000108344 Class R6

0001521894 S000035220 U.S. Intrinsic Value Series Fund

C000108347 Class R4

C000108348 Class R5

C000108349 Class R6

0001521894 S000035221 U.S. Growth Series Fund

C000108350 Class R4

C000108351 Class R5

C000108352 Class R6

0001521894 S000035222 International Core Equity Series Fund

C000108353 Class R4

C000108354 Class R5

C000108355 Class R6

0001521894 S000035223 International Large/Mid Cap Value Series Fund

C000108356 Class R4

C000108357 Class R5

C000108358 Class R6

0001521894 S000035224 International Growth Equity Series Fund

C000108359 Class R4

C000108360 Class R5

C000108361 Class R6

0001521894 S000035225 Developed World Stock Series Fund

C000108362 Class R4

C000108363 Class R5

C000108364 Class R6

0001521894 S000035226 Foreign Series Fund

C000108365 Class R4

C000108366 Class R5

C000108367 Class R6

0001521894 S000035227 Emerging Countries Series Fund

C000108368 Class R4

C000108369 Class R5

C000108370 Class R6

N-PX 1 v728133-2_npx.txt N-PX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-PX ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-22564 GMO Series Trust (Exact name of registrant as specified in charter) 40 Rowes Wharf Boston, MA 02110 (Address of principal executive offices) (Zip code) J.B. Kittredge, Principal Executive Officer GMO Trust 40 Rowes Wharf Boston, MA 02110 (Name and address of agent for service) Registrant's telephone number, including area code: (617) 330-7500 Date of fiscal year end: 4/30/12 Date of reporting period: 03/01/12 - 06/30/12 Item 1. Proxy Voting Record. Disclose the following information for each matter relating to a portfolio security considered at any shareholder meeting held during the period covered by the report and with respect to which the registrant was entitled to vote: ******************************* FORM N-Px REPORT ******************************* ICA File Number: 811-22564 Reporting Period: 07/01/2011 - 06/30/2012 GMO Series Trust =================== GMO International Equity Allocation Fund =================== There is no proxy voting activity for the fund, as the fund did not hold any votable positions during the reporting period. ========== END NPX REPORT SIGNATURES Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. (Registrant) GMO Series Trust --------------------------------------------------------------- By (Signature and Title)* /s/ J.B. Kittredge ------------------------------------------------- J.B. Kittredge, Principal Executive Officer Date August 17, 2012 --------------------------------------------------------------------- *Print the name and title of each signing officer under his or her signature. 2